Entyvio & Off label use

8.4%

of users reported Off label use

77.9%

also reported Severe reaction

50.8%

are women

Severe reaction

77.9%

Hospitalization

19.3%

Death

2.0%

Disability

0.8%

Entyvio: general information

0 - 9 years

0.1%

10 - 19 years

5.0%

20 - 29 years

14.4%

30 - 39 years

18.0%

40 - 49 years

17.9%

50 - 59 years

18.2%

60 - 69 years

15.5%

70 - 79 years

8.5%

80 - 89 years

2.4%